Unblinded safety data from Phase 2b QUALITY study expected in the second quarter of calendar 2025 -- --Topline efficacy and safety data for Phase 2b extension maintenance study expected in the second ...

Topline efficacy and safety data for Phase 2b extension maintenance study expected in the second quarter of calendar 2025 -- --With positive Phase 2b QUALITY study, Veru plans for end of Phase 2 ...

Metamorphx is emerging as a leading natural GLP-1 alternative for weight loss in 2025. With prescription options like ...

Keeping up with the GLP-1 area is a full-time job by itself. First off, you have the recent development that these drugs are ...

Although enobosarm + semaglutide significantly preserved lean mass ... high probability of success given that sabizabulin ...

The other big challenge is, despite having a variety of different therapies that we can choose, a variety of different mechanisms of action, we don’t have the ability to pinpoint the right drug ...

Ozempic, originally for type 2 diabetes, has surged in popularity in North America as a weight-loss solution, sparking a ...

Wegovy (semaglutide) is an injectable medication that’s FDA approved for weight loss and other uses. Your health insurance may deny coverage for Wegovy, but you can still access it through an ...

This review is the first to summarize the mechanisms of action and resistance associated with both ferroptosis and PARP inhibitors in ovarian cancer. Having established the core mechanisms of ...

Ozempic (semaglutide) and Wegovy (semaglutide) are prescription drugs that may be used to help with long-term weight loss. But only Wegovy is FDA approved for this use. Both drugs are approved for ...

SEMAGLUTIDE and tirzepatide have emerged as promising treatments for weight management in adults without diabetes. These glucagon-like peptide-1 (GLP-1) receptor agonists have demonstrated significant ...

GLP-1 medications like Ozempic may help reduce alcohol cravings and support recovery—especially when combined with therapy and used to treat coexisting conditions.